Optical Genome Mapping ( <scp>OGM</scp> ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma

Diagram illustrating the final OGM assessment in relation to targeted FISH analysis. On the right, the final OGM results indicate whether additional alterations were detected, no alterations were observed, genetic diagnosis was improved, or if results were inconclusive, including cases where FISH and OGM showed no concordance and OGM did not reveal any alterations.

Authors

Institutions

Publication Details

Journal
American Journal of Hematology
Published
2025-09-20
DOI
https://doi.org/10.1002/ajh.70077
Citations
1
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optical Genome Mapping ( OGM ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma

Xavier Ortı́n, Marcia Nogueira Castaldi Abel, Gladys Ibarra, Yolanda González‐Montes et al.
1 citations
American Journal of Hematology
Multiple Myeloma Research and Treatments
1.77
article

Optical Genome Mapping ( OGM ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma

Xavier Ortı́n, Marcia Nogueira Castaldi Abel, Gladys Ibarra, Yolanda González‐Montes, Lourdes Escoda, Mar Mallo, Isabel Granada, Albert Oriol, Encarnación Santafé, Laura Abril, José‐Tomás Navarro, Françesc Solé, Neus Ruiz‐Xivillé, Carmen Villena, Anna M. Sureda, Jéssica Tijero, Adela Cisneros, Aleix Méndez‐López
article en
1 citations

Abstract

Diagram illustrating the final OGM assessment in relation to targeted FISH analysis. On the right, the final OGM results indicate whether additional alterations were detected, no alterations were observed, genetic diagnosis was improved, or if results were inconclusive, including cases where FISH and OGM showed no concordance and OGM did not reveal any alterations.

American Journal of HematologyVol. 100(11)
Universitat Autònoma de Barcelona (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Josep Carreras Leukaemia Research Institute (ES), Institut Català d'Oncologia (ES), Fundación Josep Carreras Contra la Leucemia (ES), Hospital Universitari Joan XXIII de Tarragona (ES), Hospital Universitari de Tortosa Verge de la Cinta (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES)
Openalex Percentile: Top 12%
Multiple Myeloma Research and Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Optical Genome Mapping ( <scp>OGM</scp> ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma — Xavier Ortı́n, Marcia Nogueira Castaldi Abel, et al. · American Journal of Hematology (2025) | TGRS Research Map | TGRS